Compile Data Set for Download or QSAR
maximum 50k data
Found 475 with Last Name = 'rowan' and Initial = 'k'
TargetIntegrin alpha-4(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50089021((8R,13R)-13-{[1-Acetyl-3-(4-hydroxy-phenyl)-pyrrol...)
Affinity DataIC50:  0.100nMAssay Description:Compound was evaluated for VCAM-VLA-4 antagonistic activity using solid phase assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117004((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.100nMAssay Description:Inhibition of Very late antigen 4/vascular cell adhesion molecule 1 interaction in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117037((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-({1...)
Affinity DataIC50:  0.100nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117041((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-({1...)
Affinity DataIC50:  0.140nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117036((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.150nMAssay Description:Inhibition of Very late antigen 4/vascular cell adhesion molecule 1 interaction in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117056((S)-2-(2-Bromo-6-methyl-benzoylamino)-3-[4-(2,6-di...)
Affinity DataIC50:  0.200nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in ELISA.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117016((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.210nMAssay Description:Inhibition of Very late antigen 4/vascular cell adhesion molecule 1 interaction in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117050((S)-2-(2-Bromo-5-methoxy-benzoylamino)-3-[4-(2,6-d...)
Affinity DataIC50:  0.25nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in ELISA.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117073((S)-2-(2-Chloro-4-methanesulfonyl-benzoylamino)-3-...)
Affinity DataIC50:  0.25nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in ELISA.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117026((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.260nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50116998((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.290nMAssay Description:Inhibition of Very late antigen 4/vascular cell adhesion molecule 1 interaction in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117069((S)-2-(2-Chloro-6-methyl-benzoylamino)-3-[4-(2,6-d...)
Affinity DataIC50:  0.300nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in ELISA.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117053((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-(2-...)
Affinity DataIC50:  0.300nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in ELISA.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117011((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.320nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in RamosMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117028((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.330nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50108227((S)-2-[((R)-1-Benzyl-5-oxo-pyrrolidine-2-carbonyl)...)
Affinity DataIC50:  0.370nMAssay Description:Concentration required to inhibit the VCAM-Very late antigen4 (VLA4) interaction in Ramos cell-based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50095252((S)-2-[((S)-1-Benzyl-5-oxo-pyrrolidine-2-carbonyl)...)
Affinity DataIC50:  0.370nMAssay Description:Antagonistic activity against VLA-4 (derived from ramos cells) binding to recombinant human VCAM by ELISA assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117006((S)-2-{[1-(2-Acetylamino-ethyl)-cyclopentanecarbon...)
Affinity DataIC50:  0.370nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50087594((S)-2-[(1-Benzyl-5-oxo-pyrrolidine-2-carbonyl)-ami...)
Affinity DataIC50:  0.370nMAssay Description:Antagonistic activity against VLA-4 (derived from ramos cells) binding to recombinant human VCAM by ELISA assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117031((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-({1...)
Affinity DataIC50:  0.400nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117048((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-(2-...)
Affinity DataIC50:  0.400nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in Ramos.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117066((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-(2-...)
Affinity DataIC50:  0.400nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in Ramos.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117065((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-(2-...)
Affinity DataIC50:  0.420nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in Ramos.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117000((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-({1...)
Affinity DataIC50:  0.420nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117047((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-(2-...)
Affinity DataIC50:  0.440nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in ELISA.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117074((S)-2-(2-Chloro-4-hydroxy-benzoylamino)-3-[4-(2,6-...)
Affinity DataIC50:  0.460nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in ELISA.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117007((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.460nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117034((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-({1...)
Affinity DataIC50:  0.470nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117044((S)-2-(2-Bromo-benzoylamino)-3-[4-(2,6-dichloro-be...)
Affinity DataIC50:  0.490nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in Ramos.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50089019((8R,13R)-13-[(S)-2-Amino-3-(4-hydroxy-phenyl)-prop...)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of VLA-4 binding to recombinant human VCAM using Solid phase assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50089019((8R,13R)-13-[(S)-2-Amino-3-(4-hydroxy-phenyl)-prop...)
Affinity DataIC50:  0.5nMAssay Description:Compound was evaluated for VCAM-VLA-4 antagonistic activity using solid phase assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117017((S)-2-{[1-(4-Cyano-benzyl)-cyclopentanecarbonyl]-a...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in RamosMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50089023((8S,13R)-13-{[1-Acetyl-3-(4-hydroxy-phenyl)-pyrrol...)
Affinity DataIC50:  0.5nMAssay Description:Compound was evaluated for VCAM-VLA-4 antagonistic activity using Ramos cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117042((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50089019((8R,13R)-13-[(S)-2-Amino-3-(4-hydroxy-phenyl)-prop...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory concentration of the compound against VLA-4 receptor using human VCAM-VLA-4 binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50095253((S)-2-[((S)-1-Benzyl-5-oxo-pyrrolidine-2-carbonyl)...)
Affinity DataIC50:  0.520nMAssay Description:Antagonistic activity against VLA-4 (derived from ramos cells) binding to recombinant human VCAM by ELISA assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117015((S)-2-{[1-(4-Cyano-butyl)-cyclopentanecarbonyl]-am...)
Affinity DataIC50:  0.520nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117023((S)-2-{[1-(2-Azido-ethyl)-cyclopentanecarbonyl]-am...)
Affinity DataIC50:  0.530nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50095248((S)-2-[((S)-1-Benzyl-5-oxo-pyrrolidine-2-carbonyl)...)
Affinity DataIC50:  0.540nMAssay Description:Antagonistic activity against VLA-4 binding to recombinant human VCAM by ramos cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117022((S)-2-[(1-But-3-enyl-cyclopentanecarbonyl)-amino]-...)
Affinity DataIC50:  0.550nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117072((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-[(2...)
Affinity DataIC50:  0.560nMAssay Description:Inhibitory binding concentration against VCAM/VLA-4 in Ramos.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117038((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.600nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117005((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.610nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in RamosMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117029((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-({1...)
Affinity DataIC50:  0.640nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50089029((8R,13R)-13-[(S)-2-Acetylamino-3-(4-hydroxy-phenyl...)
Affinity DataIC50:  0.700nMAssay Description:Inhibition of VLA-4 binding to recombinant human VCAM using Solid phase assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50087612((S)-2-[(1-Benzyl-5-oxo-pyrrolidine-2-carbonyl)-ami...)
Affinity DataIC50:  0.740nMAssay Description:Antagonistic activity against VLA-4 (derived from ramos cells) binding to recombinant human VCAM by ELISA assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50087620((S)-2-[(1-Benzyl-5-oxo-pyrrolidine-2-carbonyl)-ami...)
Affinity DataIC50:  0.75nMAssay Description:Antagonistic activity against VLA-4 (derived from ramos cells) binding to recombinant human VCAM by ELISA assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50095247((S)-2-[((S)-1-Benzyl-5-oxo-pyrrolidine-2-carbonyl)...)
Affinity DataIC50:  0.760nMAssay Description:Antagonistic activity against VLA-4 (derived from ramos cells) binding to recombinant human VCAM by ELISA assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117024((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.800nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in RamosMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50117008((S)-3-[4-(2,6-Dichloro-benzoylamino)-phenyl]-2-{[1...)
Affinity DataIC50:  0.800nMAssay Description:Inhibitory binding concentration determined against VCAM/VLA-4 in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 475 total ) | Next | Last >>
Jump to: